Johnson & White Wealth Management’s PepsiCo PEP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$898K Buy
6,631
+351
+6% +$52.5K 0.34% 61
2026
Q1
$975K Buy
6,280
+124
+2% +$19.3K 0.41% 50
2025
Q4
$883K Buy
6,156
+768
+14% +$113K 0.38% 54
2025
Q3
$757K Sell
5,388
-292
-5% -$41.7K 0.35% 60
2025
Q2
$750K Sell
5,680
-50
-0.9% -$6.74K 0.38% 55
2025
Q1
$859K Buy
5,730
+364
+7% +$54.2K 0.48% 51
2024
Q4
$806K Buy
+5,366
New +$879K 0.49% 48
2024
Q2
Sell
-4,804
Closed -$841K 78
2024
Q1
$841K Buy
4,804
+333
+7% +$56.1K 0.61% 42
2023
Q4
$759K Buy
4,471
+258
+6% +$42.8K 0.63% 42
2023
Q3
$714K Buy
+4,213
New +$765K 0.65% 40
2023
Q2
Sell
-4,207
Closed -$767K 62
2023
Q1
$767K Buy
+4,207
New +$735K 0.68% 35
2022
Q4
Sell
-3,848
Closed -$628K 110
2022
Q3
$628K Buy
+3,848
New +$663K 0.71% 34

Other funds holding PEP

Johnson & White Wealth Management's PEP Position: Q2 2026 in Review

Johnson & White Wealth Management increased its PepsiCo (PEP) stake by 5.6% in Q2 2026, buying an estimated $52.5K and bringing the position to 6,631 shares worth $898K. The position accounts for 0.34% of the portfolio, ranked #61.

Johnson & White Wealth Management first reported a position in PEP in Q3 2022 and has held it in 12 quarters since. The position peaked at $975K in Q1 2026. 1,136 funds tracked by Wall St. Rank hold PEP as of Q2 2026.

  • Johnson & White Wealth Management held 6,631 shares of PepsiCo worth $898K as of Q2 2026.
  • Johnson & White Wealth Management bought 351 PepsiCo shares in Q2 2026, an estimated $52.5K.
  • PepsiCo made up 0.34% of Johnson & White Wealth Management's portfolio in Q2 2026, its #61 holding.
  • Johnson & White Wealth Management first reported a position in PepsiCo in Q3 2022 and has held it in 12 quarters since.
  • Johnson & White Wealth Management's PepsiCo position peaked at $975K in Q1 2026.
  • 1,136 funds tracked by Wall St. Rank held PepsiCo as of Q2 2026.

Based on Johnson & White Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.